Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
108,881,625
-
Share change
-
+2,086,728
-
Total reported value
-
$9,006,038,986
-
Put/Call ratio
-
44%
-
Price per share
-
$82.71
-
Number of holders
-
493
-
Value change
-
+$195,338,163
-
Number of buys
-
245
-
Number of sells
-
192
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2024
As of 31 Dec 2024,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
493 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,881,625 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, JPMORGAN CHASE & CO, Burgundy Asset Management Ltd., CITADEL ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Sculptor Capital LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
497
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.